HIRO and OncoRay Lecture ­Series "Radiation Research in ­Oncology": Translational Radiooncology (Prof. Dr. Dr. Amir Abdollahi)

A central aim is to train junior scientists in interdisciplinary research, by equipping them with essential prerequisites for productive scientific cooperation: active communication between researchers and a solid understanding of the research field. The lecture series "Radiation Research in Oncology" aims to address these goals with 18 talks over the course of 2 years (2x9 lectures). The lectures are aimed at a general audience with the goal of providing an overview of each of a wide range of topics relevant to radiooncological research, including in the fields of medicine, biology, chemistry, physics and technology.

In  this  HIRO  research  focus  high  precision  radiation  oncology  is  integrated  into  curative multimodal therapy concepts. In field of precision radiotherapy, the radiobiological impact of novel particle therapy qualities i.e. proton, helium, carbon to oxygen ions developed at HIT are investigated.This unique beam parameter space is utilized to identify strategies to eradicate resistant tumor subpopulations such as hypoxic and stem-cell like cells and to explore their impact  on  tumor-immune  microenvironment  communication.  Towards  broadening  the therapeutic window, investigation of normal tissue tolerance to multimodal therapies and their effect on inflammatory response, organ dysfunction and ultimately development of fibrosis are also of utmost significance. Inevitably, precision therapy requires precision diagnostic to stratify or even personalize treatment. With a reverse translation approach, compendium imaging and molecular  diagnostics  are  developed  to  select  patients  most  benefiting  from  designed multimodal therapy strategies within a program. Overall,  mission of this research area is to develop the next generation radiation oncology by integrating the rapidly evolving field of cellular- and molecular biology into a multidisciplinary adaptive radiotherapy.

Talks in this lecture series are open to anyone who is interested, but are particularly aimed at PhD students at DKFZ. However: the lecture series is not open to the public! Only members of HIRO, OncoRay or other DKTK institutes can participate.

Until further notice, the lecture series will take place online only. All DKFZ employees will be invited by e-mail with the required login credentails.

Please note: PhD students at DKFZ please additionally register via the Training Portal of DKFZ to get your credit points! To get 0,5 credit points per part (Oct. - Jun.), you need to attend at least 6 out of 9 lectures. This lecture does not replace the Progress in Cancer Research (PiCR) lecture series!

Interested colleagues from other partner institutes of HIRO or DKTK, please contact Anna Moshanina (a.moshanina(at)dkfz-heidelberg.de) or Marcel Schäfer via e-mail (marcel.schaefer(at)dkfz-heidelberg.de) to get all relevant information. Please use your business e-mail address to register for the lecture series.